Extracellular aminoacids in the amygdala and nucleus accumbens in the rat during acute pain;Aminoácidos extracelulares en la amígdala y el núcleo accumbens en la rata durante el dolor agudo

Investigacion Clinica

Volumn 48, Issue 2, 2007, Pages 213-224

  Silva, Elizabeth ^a,b   Hernández, Luis ^a  

^a UNIVERSIDAD DE LOS ANDES   (Venezuela)

^b NONE   (Venezuela)

Author keywords

Amino acids; Amygdala; Capillary electrophoresis; Formalin test; Microdialysis; Nucleus accumbens

Indexed keywords

AMINO ACID; ARGININE; ASPARTIC ACID; FORMALDEHYDE; GLUTAMIC ACID;

AMYGDALOID NUCLEUS; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CAPILLARY ZONE ELECTROPHORESIS; CONTROLLED STUDY; FLUORESCENCE; MICRODIALYSIS; NONHUMAN; NUCLEUS ACCUMBENS; PAIN; RAT;

ACUTE DISEASE; AMYGDALA; ANIMALS; ARGININE; ASPARTIC ACID; GLUTAMIC ACID; MALE; NUCLEUS ACCUMBENS; PAIN; RATS; RATS, WISTAR;

EID: 34547110813     PISSN: 05355133     EISSN: 05355133     Source Type: Journal    
DOI: None     Document Type: Article

References (60)

1. Roger RJ. Influence of intra amygdaloid opiate injection on shock threshold, tail flick latencies and open field behavior in rats. Brain Res 1978; 153:211-216.
2. Herz A, Albus K, Metys J, Schubert P, Teschmacher H. On the central sites of the antinociceptive action of morphine and fentanyl. Neuropharmacology 1970; 9:539-551.
3. Yaksh L, Rudy TA. Narcotics analgesia: CNS sites and mechanism of action as revealed by intracerebral injection techniques. Pain 1978; 4:71-78.
4. Dill RE, Costa E. Behavioral dissociation of the enkephalinergic system of the nucleus accumbens and nucleus caudate. Neuropharmacology 1977; 16:323-326.
5. Ma QP, Han JS. Naloxone blocks opioid peptide release in the periaqueductal gray and amygdala elicited by morphine injected into Nucleus Accumbens. Peptides 1992; 13:261-265.
6. Schmidt BL, Tambeli CH, Levine JD, Gear RW. Mu/delta cooperativity and opposing kappa-opioid effects in nucleus accumbens-mediated antinociception in rats. Eur J Neurosci 2002, 15:861-868.
7. Narita M, Kishimoto Y, Ise Y, Yajima Y, Misawa K, Suzuki T. Direct evidence for the involvement of mesolimbic kappa-opioid system in the morphine-induced rewarding effect under an inflammatory pain-like satate. Neuropsychopharmaeology 2005; 30:111-118.
8. Fusa K, Takahashi I, Watanabe S, Aono Y, Ikeda H, Saigusa T, Nagase H, Suzuki T, Koshikawa N, Cools AR. The non-peptidic delta oioid receptor agonist TAN-67 enhances dopamine efflux in the nucleus accumbens of freely moving rats via a mechanism that involves both glutamate and free radicals. Neuroscience 2005; 130:745-755.
9. Zhang XJ, Xu MY, Ly N. Influence of glutamate and NMDA-receptor antagonist MK-801 on the electric activities of pain-excitation neurons in the nucleus accumbens of rats. Sheng Li Xue Bao 2005; 571:66-70.
10. Yu LC, Han JS. The neural pathway from nucleus accumbens to amygdala in morphine analgesia in the rabbit. Sheng Li Xue Bao 1990; 42:277-283.
11. Magnusson JE, Martin RV. Additional evidence for the involvement of the basal ganglio in formalin-induced nociception: the role of nucleus accumbens. Brain Res 2002; 942:128-133
12. Zhou ZF, Du MY, Wu WY, Jiang Y, Han JS. Effects of intracerebral microinjection of naloxone on acupuncture and morphine analgesia in the rabbit. Sci Sin 1981; 24:1166-1178.
13. Helmstetter FJ, Bellgowan PS, Tershner SA. Inhibition of tail flick reflex following microinjection of morphine in the amygdala. Neuroreport 1995; 4:471-474.
14. Helmstetter FJ, Bellgowan PSF, Poore LH. Microinfusion of mu but not delta o kappa opioid antagonist in the basolateral amygdala results in inhibition of tail flick reflex in pentobarbital anesthetized rats. J Pharmacol Exp Ther 1995; 275:381-388.
15. Pavlovic ZW, Cooper ML, Bodnar R. Opioid antagonist in periaqueductal gray inhibit morphine and beta endorphin analgesia elicited by the amygdala of rat. Brain Res 1996; 741:13-26.
16. Pavlovic ZW, Bodnar RJ. Opioid supraspinal analgesia synergy between the amygdala and the periaqueductal gray in rats. Brain Res 1998; 779:158-169.
17. Fox JR, Sorensen CA. Bilateral lesions in the amygdala attenuate analgesia induced by diverse environmental challenges. Brain Res 1994; 648:215-221.
18. Guirimand F, Le Bars D. Physiology of nociception. Ann Fr Anesth Reanim 1996; 15:1048-1079.
19. Helmstetter FJ, Tershner SA, Poore LH, Bellgowan PSF. Antinociception following opioid stimulation of the basolateral amygdala is expressed through the periaqueductal gray and rostral ventromedial medulla. Brain Res 1998; 779:104-118.
20. Minami M. Molecular pharmacology of opioid receptors. Nippon Yakurigaku Zasshi 2004; 123:95-104.
21. Shors TJ, Elkabes S, Selcher JS, Black IB. Stress persistently increases NMDA receptor mediated binding (311) PDBu (a marker for protein kinase C) in the amygdala, and re-exposure to the stressful context reactivates the increase. Brain Res 1997; 750:293-300.
22. Silva E, Quiñonez B, Freund N, Gonzalez LE, Hernandez L. Extracellular glutamate, aspartate and arginine in the ventral posterolateral thalamic nucleus during nociceptive stimulation, Brain Res 2001; 923:45-49.
23. Abarca C, Silva E, Sepulveda J, Oliva P, Contreras E. Neurochemical changes after morphine, Dizocilpine or riluzole in the ventral posterolateral thalamic nuclei of rats with hyperalgesia. Eur J Pharmacol 2000; 403:67-74.
24. Silva E, Hernandez L, Contreras Q, Guerrero F, Alba G. Noxious stimulation increased glutamate and arginine in the periaqueductal gray matter in rats: a microdialysis study. Pain 2000; 80:131-135.
25. Fundytus ME. Glutamate receptors and nociception. Implications for the drug treatment of pain. Review article. CNS Drugs 2001; 15:29-57.
26. Meller ST, Gebhart GF. Nitric oxide (NO) and nociceptive processing in the spinal cord. Pain 1993; 52:127-136.
27. Moncada S, Palmer RMJ, Higgis A. Nitric oxide. Physiology, pathology and pharmacology. Phamacol Rev 1991; 43:109-142.
28. Grima G, Benz B, Do KQ. Glial-derived arginine, the nitric oxide precursor, protects neurons from NMDA-induced excitotoxicity. Eur J Neurosc 2001; 14: 1762-1770.
29. Hernandez L, Stanley BG, Hoebel BG. A small removable microdialysis probe. Life Sci 1986; 39:2629-2637.
30. Hernandez L, Tucci S, Guzman N, Paez X. In vivo monitoring glutamate in the brain by microdialysis in the laser induced fluorescence detection. J Chromatography 1993; 625:393-398.
31. Paxinos G, Watson C. The rat brain in stereotaxic coordinates, Second Ed. 1986, Academic Press, San Diego. USA.
32. Wheeler-Aceto A, Porreca F, Cowan A. The rat formalin test: comparision of noxiousagents. Pain 1990; 40:229-223.
33. 2 and amino acids evoked by paw formalin injection: a microdialysis study in ananesthetized rats. J Neurosc 1995; 15:2768-2776.
34. Cooper JR, Bloom FE, Roth RH. The Biochemical Basis of Neuropharmacology. Cap 6 Amino Acid Transmitters. Seventh Edition. 1996. Oxford University Press. New Cork; pp171-193.
35. Mogenson GJ, Jones DL, Yim CY. From motivation to action: fundamental interface between the limbic system and the motor system. Prog Neurobiol 1980; 14:69-97.
36. Manning BH, Morgan MJ, Franking KB. Morphine analgesia in the formalin test: evidence for forebrain and midbrain sites of action. Neuroscience 1994; 63:284-294.
37. Xuan YT, Shi YS, Zhorn ZF, Han JS. Studies on the mesolimbic loop of antinoeiception II. A serotonin-enkephalin interaction in the nucleus accumbens. Neuroscience 1982; 19:403-409.
38. Rada P, Tucci S, Murzi E, Hernández L. Extracellular glutamate increases in the lateral hypothalamus and decreases in the nucleus accumbens during feeding. Brain Res 1997; 768:338-340.
39. Saul'skaya NB, Solov'eva NA, Savel'ev SA. Glutamate release in the nucleus accumbens during competitive presentation of aversive and appetitive stimuli. Neurosci Behav Physiol 2006; 36:247-252.
40. Moghaddam B. Stress prefentially increases extraneuronal levels of excitatory amino acids in the prefrontal cortex: comparision to hyppocampus and basal ganglia. J Neurochem 1993; 60:1650-1657.
41. Druhan JP, Rajabi H, Stewart J. MK-801 increases locomotor activity without elevating extracellular dopamine levels in the nucleus accumbens. Synapse 1996; 24: 135-146.
42. Leonibus E, Mele A, Oliverio A, Pert A. Locomotor activity induced by the non-competitive N-methyl-D-aspartate antagonist, MK-801: role of nucleus accumbens efferent pathways. Neuroscience 2001; 104:105-116.
43. Becerra LR, Breiter HC, Stojanovic M, Fishman S, Edwards A, Comite AR, Gonzalez RG, Borsook D. Human brain activation under controlled termal stimulation and habituation to noxious heat: an fMRI study. Magn Reson Med 1999, 41:1044-1057.
44. Bingel U, Quante M, Knab R, Bromm B, Weiller C, Buchel C. Subcortical structures involved in pain processing: evidence from single-trial fMRI. Pain 2002; 99: 313-321.
45. Bonaz B, Baciu M, Papillon E, Bost R, Gueddah N, Le Bas JF, Fournet J, Segebarth C. Central processing of rectal pain in patients with irritable bowel syndrome: an fMRI study. Am J Gastroenterol 2002; 97:654-661.
46. Bornhovd K, Quante M, Glauche V, Bromm B, Weiller C, Buchel C. Painful stimuli evoke different stimulus-response functions in the amygdala, prefrontal, insula, and somatosensory cortex: a single-trial fMRI study. Brain 2002; 125(Pt 6): 1326-1336.
47. Derbyshire SW, Jones AK, Gyulai F, Clark S, Townsend D, Firestone LL. Pain processing during three levels of noxious stimulation produces differential patterns of central activity. Pain 1997; 73:431-445.
48. Schneider F, Habel U, Holthusen H, Kessler C, Posse E, Muller-Gartner HW, Arndt JO. Subjective ratings of pain correlate with subcortical-limbic blood flow: an fMRI study. Neuropsychobiology 2001; 43:175-178.
49. Villemure C, Wassimi S, Bennett GJ, Shir Y, Bushnell MC. Unpleasent odors increase pain processing in a patient with neurophatic pain: psychophysical and fMRI investigation. Pain 2006; 120:213-220.
50. Paulson PE, Casey KL, Morrow TJ. Long-term changes in behavior and regional cerebral blood flor associated with painful peripheral mononeuropathy in the rat. Pain 2002; 95:31-40.
51. Doron NN, Ledoux JE. Cells in the posterior thalamus Project to both amygdala and temporal cortex: a quantitative retrograde double-labeling study in the rat. J. Comp Neurol 2000; 425:257-274.
52. Doron NN, Ledoux JE. Organization of projections to the lateral amygdala from auditory and visual areas of the thalamus of the rat. J Comp Neurol 2000; 417:385-386.
53. Linke R. Differential projection patterns of superior and inferior collieular neurons onto posterior paralaminar nuclei of the thalamus surrounding the medial geniculate body in the rat. Eur J Neurosci 1999; 11:187-203.
54. Pitkanen A, Savander V, LeDoux JE. Organization of intra-amygdaloid circuitries in the rat: an emerging framework for understanding functions of the amygdale. Trends in Neurosci 1997; 20:517-523.
55. Shi C, Davis M. Pain pathways envolved in fear conditioning measured with fear-potetiated startle: lesions study. J Neurosci 1999; 19:420-430.
56. Bourgeais L, Gauriau C, Bernard JF. Projections from the nociceptive area of central nucleus of the amygdala to the forebrain: a PHA-L study in the rat. Eur J Neurosci 2001; 14: 229-255.
57. Jasmin L, Burkey AR, Card JP, Basbaum AL. Transneuroral labeling of a nociceptive pathway, the spino-(trigemino-) parabrachioamygdaloid, in the rat. J Neurosci 1997; 17: 3751-3765.
58. Tucci S, Rada P, Hernandez L. Role of glutamate in the amygdala and lateral hypothalamus in conditioned test aversion. Brain Res 1988; 8:44-49.
59. Schafe GE. Bauer EP, Rosis S, Farb CR, Rodríguez SM, LeDoux JE. Memory consolidation of Pavlovian fear conditioning requires nitric oxide signaling in the lateral amygdala. Eur J Neurosc 2005, 22: 201-211.
60. Sahraei H, Pirzadeh-Jahromi G, Noorbakhsnia M, Asgari A, Haeri-Rohani A, Khoshbaten A, Poorheidari GR, Sepehri H, Ghoshooni H, Zarrindast MR. Involvement of nucleus accumbens in L-arginine-induced conditioned place preferente in rats. Behav Pharmacol 2004; 15:473-480.